Paris - France

Founded in 1999, PELVIPHARM is a spin-off from the University of Versailles-Saint-Quentin-en-Yvelines (France) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliable contract research services :

Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication
Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action
Identification of new properties or attributes supporting differentiation of medications within the class or between classes
Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities

  • Category:

    Biotechnology - Genetic Engineering

  • Description:

    PELVIPHARM - Preclinical outsourcing CRO in sexual dysfunction (ED, FSD,PE), cardiovascular & diabetes pharmacology & urology (overactive bladder, bph, detrusor overactivity, interstitial cystitis/Painful bladder syndrome, urinary incontinence).
    Founded in 1999, PELVIPHARM is a contract research organization (CRO) delivering preclinical services in urology (BPH, OAB, NDO, SCI, SUI, IC/Painful bladder syndrome ), sexual (ED, PE, FSD ) and cardiovascular medicine (Hypertension, Atherosclerosis, Metabolic Syndrome, Diabetes, Myocardical Infarction ) using both in vivo experimental models and in vitro animal and human tissue-based specific research services.


    Contract Research Organization


Contract research organization delivering preclinical services in urology and cardiovascular medicine, with experience in pathophysiology, pharmacology, clinical research and medical practice.